 |
市場調查報告書
商品編碼
1529920
危急性肢體缺血治療市場：依藥物、給藥途徑、最終用戶及地區Critical Limb Ischemia Treatment Market, By Drugs, By Route of administration, By End User, By Geography |
||||||
價格
簡介目錄
預計2024年全球危急性肢體缺血治療市場規模為51億美元，預計2031年將達91.1億美元，2024年至2031年複合年成長率為8.6%。
| 報告範圍 | 報告詳情 | ||
|---|---|---|---|
| 基準年 | 2022年 | 2024年市場規模 | 51億美元 |
| 實際資料 | 2018-2021 | 預測期 | 2024-2031 |
| 2024-2031 年預測期複合年成長率 | 8.60% | 2031 年金額預測 | 91.1億美元 |
圖：2024 年按地區分類的危急性肢體缺血治療市場佔有率(%)
全球危急性肢體缺血治療市場是指四肢（例如腳部）血液循環顯著減少的醫療狀況。這是一種嚴重的疾病，如果不及時治療，可能會導致截肢。這種情況是由於脂肪物質在動脈內積聚而引起的，從而導致動脈硬化。血流受到限制，導致四肢劇烈疼痛和潰瘍且無法癒合。由於老年人口的增加、周邊動脈疾病病例的增加以及對可用治療方案的認知不斷提高，全球危急性肢體缺血治療市場預計將在未來幾年顯著成長。
市場動態：
全球危急性肢體缺血治療市場是由糖尿病（CLI 的主要危險因子）盛行率上升以及全球老年人口不斷增加所推動的。此外，用於開發先進治療設備和藥物的研究經費的增加也推動了市場的成長。然而，血管成形術和血管手術的高昂費用阻礙了患者獲得治療。已開發國家對 CLI 的認知不斷提高以及報銷計劃的可用性提供了一個有利可圖的機會。
本研究的主要特點
- 該報告對全球危急性肢體缺血治療市場進行了詳細分析，包括以2023年為基準年的預測期（2024-2031年）的市場規模（十億美元）和年複合成長率（CAGR%）。 。
- 它還揭示了各個細分市場的潛在商機，並說明了該市場有吸引力的投資提案矩陣。
- 它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。
- 根據公司亮點、產品系列、主要亮點、績效和策略等參數對全球危急性肢體缺血治療市場的主要企業進行了分析。
- 該報告的見解使負責人和公司經營團隊能夠就未來的產品發布、升級、市場擴張和行銷策略做出明智的決策。
- 全球危急性肢體缺血治療市場報告針對該行業的各個相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
- 透過用於全球危急性肢體缺血治療市場分析的各種策略矩陣，將有助於相關人員做出決策。
目錄
第1章 研究目的與前提
- 研究目的
- 先決條件
- 簡稱
第2章 市場展望
- 報告說明
- 市場定義和範圍
- 執行摘要
- 一致的機會地圖 (COM)
第3章市場動態、法規及趨勢分析
- 市場動態
- 促進因素
- 抑制因素
- 機會
- 影響分析
- 市場趨勢
- 監管場景
- 收購和合作場景
- 資金籌措和投資
- PEST分析
- 波特的分析
第4章全球危急性肢體缺血治療市場 - 冠狀病毒（COVID-19）大流行的影響
- 整體影響
- 政府舉措
- COVID-19 對市場的影響
第5章全球危急性肢體缺血治療市場，依藥物分類，2019-2031（十億美元）
- 介紹
- 抗高血壓藥
- 抗血小板藥物
- 抗血栓劑
- 降血脂劑
- 其他
第6章 全球危急性肢體缺血治療市場，依給藥途徑，2019-2031 年（十億美元）
- 介紹
- 口服
- 母親與孩子之間
第7章 全球危急性肢體缺血治療市場，依最終用戶分類，2019-2031 年（十億美元）
- 介紹
- 醫院
- 專科診所
- 門診手術中心
- 老人安養院
- 其他
第8章全球危急性肢體缺血治療市場，按地區，2019-2031（十億美元）
- 介紹
- 拉丁美洲
- 歐洲
- 亞太地區
- 中東
第9章 競爭格局
- 公司簡介
- Advanced Brain Monitoring, Inc.
- Medtronic plc
- fic Corporation
- Abbott Laboratories
- Cook Medical Inc.
- Cardiovascular Systems, Inc.
- Philips Healthcare
- B. Braun Melsungen AG
- Terumo Corporation
- Biotronik SE &Co. KG
- Cordis Corporation
- Smith &Nephew plc
- Stryker Corporation
- AngioDynamics, Inc.
- GE Healthcare
- Sanofi SA
- AstraZeneca plc
- Bristol-Myers Squibb Company
第10章分析師建議
- 上升和下降
- 綜合機會圖
第11章 參考文獻與調查方法
- 參考
- 調查方法
簡介目錄
Product Code: CMI7115
The global critical limb ischemia treatment market is estimated to be valued at USD 5.10 Bn in 2024 and is expected to reach USD 9.11 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 8.6% from 2024 to 2031.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2022 | Market Size in 2024: | US$ 5.10 Bn |
| Historical Data for: | 2018 to 2021 | Forecast Period: | 2023 - 2030 |
| Forecast Period 2024 to 2031 CAGR: | 8.60% | 2031 Value Projection: | US$ 9.11 Bn |
Figure. Critical Limb Ischemia Treatment Market Share (%), By Region 2024
Global critical limb ischemia treatment market refers to the medical condition where the blood circulation to extremities like legs is severely reduced. This is a serious condition that can lead to amputation if left untreated. The condition arises due to the accumulation of fatty substances in arteries leading to atherosclerosis. The limited blood flow leads to severe pain and sores on extremities which do not heal. The global critical limb ischemia treatment market is poised to grow significantly in the coming years due to increasing geriatric population, rising cases of peripheral artery diseases, and growing awareness regarding available treatment options.
Market Dynamics:
The global critical limb ischemia treatment market is driven by the rising prevalence of diabetes and growing geriatric population globally which are major risk factors for CLI. Additionally, increasing research funding for the development of advanced treatment devices and drugs is also boosting the market growth. However, high cost of angioplasty and vascular surgeries hampers patient's accessibility to treatment. Growing awareness about CLI and availability of reimbursement coverage in developed nations provides lucrative opportunities.
Key Features of the Study:
- This report provides in-depth analysis of the global critical limb ischemia treatment market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global critical limb ischemia treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Medtronic, Boston Scientific, Cardinal Health, Terumo, Abbott Laboratories, etc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global critical limb ischemia treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global critical limb ischemia treatment market
Detailed Segmentation-
- By Drugs
- Antihypertensive Agents
- Antiplatelet Drugs
- Antithrombotic Agents
- Lipid-lowering Agents
- Others
- By Route of administration
- Oral
- Parentral
- Others
- By End User
- Hospitals
- Specialty Clinics
- Ambulatory Surgery Centers
- Nursing Homes
- Others (Rehabilitation Centers, etc.)
- By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Company Profiles:
- Medtronic plc
- Boston Scientific Corporation
- Abbott Laboratories
- Cook Medical Inc.
- Cardiovascular Systems, Inc.
- Philips Healthcare
- Braun Melsungen AG
- Terumo Corporation
- Biotronik SE & Co. KG
- Cordis Corporation
- Smith & Nephew plc
- Stryker Corporation
- AngioDynamics, Inc.
- GE Healthcare
- Sanofi S.A.
- AstraZeneca plc
- Bristol-Myers Squibb Company
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Drugs
- Market Snapshot, By Route of Administration
- Market Snapshot, By End User
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Scenario
- Acquisitions and Partnerships Scenario
- Funding and Investments
- PEST Analysis
- Porter's Analysis
4. Global Critical Limb Ischemia Treatment Market - Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact
- Government Initiatives
- COVID-19 Impact on the Market
5. Global Critical Limb Ischemia Treatment Market, By Drugs, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
- Antihypertensive Agents
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Antiplatelet Drugs
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Antithrombotic Agents
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Lipid-lowering Agents
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
6. Global Critical Limb Ischemia Treatment Market, By Route of Administration 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
- Oral
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Parentral
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
7. Global Critical Limb Ischemia Treatment Market, By End User, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
- Hospitals
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Specialty Clinics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Ambulatory Surgery Centers
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Nursing Homes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
8. Global Critical Limb Ischemia Treatment Market, By Region, 2019 - 2031, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2019-2031
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drugs, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drugs, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drugs, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drugs, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drugs, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drugs, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- North Africa
- Central Africa
- South Africa
9. Competitive Landscape
- Company Profiles
- Advanced Brain Monitoring, Inc.
- Company Highlights
- Drugs Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Medtronic plc
- Boston Scienti Company Highlights
- Drugs Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- fic Corporation
- Company Highlights
- Drugs Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Abbott Laboratories
- Company Highlights
- Drugs Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Cook Medical Inc.
- Company Highlights
- Drugs Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Cardiovascular Systems, Inc.
- Company Highlights
- Drugs Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Philips Healthcare
- B. Braun Melsungen AG
- Terumo Corporation
- Biotronik SE & Co. KG
- Cordis Corporation
- Smith & Nephew plc
- Stryker Corporation
- AngioDynamics, Inc.
- GE Healthcare
- Sanofi S.A.
- AstraZeneca plc
- Bristol-Myers Squibb Company
- Advanced Brain Monitoring, Inc.
10. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
11. Reference and Research Methodology
- References
- Research Methodology
- About us and Sales Contact
